DIABETIC RANGE
Composition :
Empagliflozin 10 mg
Packaging :
10×10
General Dosage :
Adults: One tablet daily or as directed by the physician.
General Usage :
Commonly prescribed for the management of type 2 diabetes mellitus, helping to improve glycemic control and reduce the risk of cardiovascular complications.
Composition :
Empagliflozin 25 mg
Packaging :
10×10
General Dosage :
Adults: One tablet daily or as directed by the physician.
General Usage :
Commonly prescribed for type 2 diabetes mellitus in patients requiring stronger glucose-lowering therapy, while also providing cardiovascular and renal protective benefits.
Composition :
Empagliflozin 12.5 mg + Metformin 500 mg
Packaging :
10×10
General Dosage :
Adults: One tablet daily, preferably with meals, or as directed by the physician.
General Usage :
Commonly prescribed for type 2 diabetes mellitus in patients requiring dual therapy, combining SGLT2 inhibition with metformin for improved glycemic control and added cardio-renal benefits.
Composition :
Glimepiride 2mg, Voglibose 0.2mg, Metformin HCl (SR) 500mg
Packaging :
10 x 10
General Dosage :
Adults: One tablet once daily with meals or as prescribed.
General Usage :
Indicated for type 2 diabetes mellitus to improve glycemic control where combination therapy is needed for insulin resistance and postprandial hyperglycemia.
Composition :
Glimepiride 2mg, Pioglitazone HCl 15mg, Metformin HCl (ER) 500mg
Packaging :
10 x 10
General Dosage :
Adults: One tablet once daily or as advised.
General Usage :
Used for type 2 diabetes mellitus patients requiring multiple mechanisms: insulin sensitization, insulin release, and glucose lowering.
Composition :
Gliclazide 80mg, Metformin HCl 500mg
Packaging :
10 x 10
General Dosage :
Adults: One tablet twice daily or as directed.
General Usage :
Indicated for type 2 diabetes mellitus, particularly in patients with mild to moderate insulin resistance needing dual therapy.
Composition :
Glimepiride 1mg, Metformin HCl (ER) 500mg
Packaging :
10 x 10
General Dosage :
Adults: One tablet once daily or as prescribed.
General Usage :
Used for newly diagnosed type 2 diabetic patients to achieve glucose control through insulin secretion and improved insulin sensitivity.
Composition :
Glimepiride 2mg, Metformin HCl (ER) 500mg
Packaging :
10 x 10
General Dosage :
Adults: One tablet once daily or as prescribed.
General Usage :
Indicated for patients with type 2 diabetes mellitus requiring enhanced glycemic control through dual oral therapy.
Composition :
Sitagliptin 50mg
Packaging :
10 x 15 (Blister)
General Dosage :
Adults: One tablet once daily or as directed.
General Usage :
Used in type 2 diabetes mellitus as DPP-4 inhibitor to improve glycemic control by increasing insulin release and reducing glucagon secretion.
Composition :
Sitagliptin 100mg
Packaging :
10 x 15 (Blister)
General Dosage :
Adults: One tablet once daily or as directed.
General Usage :
Indicated for type 2 diabetes mellitus either as monotherapy or in combination with other antidiabetic agents for glycemic control.
Composition :
Sitagliptin 50mg, Metformin 500mg
Packaging :
10 x 15 (Blister)
General Dosage :
Adults: One tablet once daily or as directed.
General Usage :
Used for type 2 diabetes mellitus for combined effect on insulin sensitivity and incretin pathway control.
Composition :
Sitagliptin 50mg, Metformin 1000mg
Packaging :
10 x 15 (Blister)
General Dosage :
Adults: One tablet once or twice daily as advised.
General Usage :
Indicated for patients with inadequate glycemic control on metformin alone requiring incretin-based dual therapy.
Composition :
Sitagliptin 100mg, Dapagliflozin 10mg, Metformin 500mg
Packaging :
10 x 10 (Alu-Alu)
General Dosage :
Adults: One tablet once daily or as prescribed.
General Usage :
Used for advanced type 2 diabetes requiring triple therapy for optimal glycemic control via insulin sensitivity, glucose excretion, and incretin effect.
Composition :
Vildagliptin 50mg
Packaging :
20 x 10 x 15
General Dosage :
Adults: One tablet once or twice daily as advised.
General Usage :
Indicated for type 2 diabetes mellitus where DPP-4 inhibition is required to improve glycemic control and insulin response.
Composition :
Vildagliptin 50mg, Metformin HCl 500mg
Packaging :
6 x 15
General Dosage :
Adults: One tablet once or twice daily as directed.
General Usage :
Used for combination management of type 2 diabetes for improved insulin sensitivity and glucose regulation.
Composition :
Vildagliptin 50mg, Metformin HCl 1000mg
Packaging :
6 x 15
General Dosage :
Adults: One tablet once or twice daily or as prescribed.
General Usage :
Indicated for patients requiring higher metformin dose along with incretin pathway regulation in type 2 diabetes mellitus.
Composition :
Teneligliptin 20mg
Packaging :
10 x 10
General Dosage :
Adults: One tablet once daily as advised.
General Usage :
Indicated for type 2 diabetes mellitus for DPP-4 inhibition improving glycemic control.
Composition :
Teneligliptin 20mg, Metformin HCl 500mg (ER)
Packaging :
10 x 10
General Dosage :
Adults: One tablet once or twice daily or as directed.
General Usage :
Used for type 2 diabetes mellitus where combined DPP-4 inhibition and metformin therapy are required.
Composition :
Teneligliptin 20mg, Metformin HCl 1000mg (ER)
Packaging :
10 x 10 (Alu-Alu)
General Dosage :
Adults: One tablet once or twice daily or as directed.
General Usage :
Indicated for improved glycemic control in type 2 diabetes mellitus patients inadequately controlled on monotherapy.
Composition :
Dapagliflozin 10mg
Packaging :
10 x 10
General Dosage :
Adults: One tablet once daily or as directed.
General Usage :
Indicated for type 2 diabetes mellitus for glucose lowering via SGLT2 inhibition, and also provides cardiovascular and renal protection.
Composition :
Dapagliflozin 5mg, Metformin HCl 500mg (SR)
Packaging :
10 x 10
General Dosage :
Adults: One tablet once or twice daily as advised.
General Usage :
Used for combined glycemic control and weight management in type 2 diabetes patients.
Composition :
Dapagliflozin 10mg, Metformin HCl 500mg (SR)
Packaging :
10 x 10
General Dosage :
Adults: One tablet once or twice daily as advised.
General Usage :
Indicated for type 2 diabetes mellitus for improved glycemic control and prevention of diabetes-related complications.
Composition :
Glimepiride 1 mg, Voglibose 0.2 mg, Metformin HCl (SR) 500 mg
Packaging :
10×10
General Dosage :
Adults: One tablet daily, preferably with meals, or as directed by the physician.
General Usage :
Commonly prescribed for the management of type 2 diabetes mellitus, helping to improve glycemic control by reducing blood glucose levels through complementary mechanisms of action.
Composition :
Glimepiride 2 mg, Voglibose 0.2 mg, Metformin HCl (SR) 500 mg
Packaging :
10×15
General Dosage :
Adults: One tablet daily, preferably with meals, or as directed by the physician.
General Usage :
Commonly prescribed for the management of type 2 diabetes mellitus, providing enhanced glycemic control in patients requiring a higher dose of glimepiride along with voglibose and sustained-release metformin.
Composition :
Voglibose 0.3mg
Packaging :
10 x 10
General Dosage :
Adults: One tablet before meals or as prescribed.
General Usage :
Used to control postprandial hyperglycemia in type 2 diabetes by delaying carbohydrate absorption.
Composition :
Linagliptin 5mg
Packaging :
10 x 15
General Dosage :
Adults: One tablet once daily as directed.
General Usage :
Indicated for type 2 diabetes mellitus via DPP-4 inhibition with renal safety advantage.
Composition :
Linagliptin 2.5mg, Metformin HCl IP 500mg
Packaging :
10 x 15
General Dosage :
Adults: One tablet once or twice daily or as advised.
General Usage :
Used for combination therapy in type 2 diabetes for better glycemic control via DPP-4 inhibition and insulin sensitivity.